Jobs and People

16 June 2003 00:00  [Source: ICB Americas]

Daniel M. Bradbury

Daniel M. Bradbury has been named chief operating officer at Amylin Phar-maceuticals Inc. Mr. Bradbury has been with the company since 1994, most recently as vice president. He will have expanded responsibilities for the research, development and clinical ca-pabilities of the company.

Barry Brandstetter

Barry Brandstetter has been named vice president of marketing at Xanodyne Pharmacal Inc. He has nearly 30 years of pharmaceutical experience. Most recently, Mr. Brandstetter was executive vice president of Gerbig, Snell/Weisheimer, a large health care advertising and marketing communications company.

Tatiana Brask

Tatiana Brask has joined Genmab A/S's investor and public relations team effective July 1. Ms. Brask has a broad background in the international financial community. Most recently, she worked as a senior analyst at the European investment bank WestLB Panmure with responsibility for covering Nordic pharmaceutical companies as well as Genmab.

Ruth Dreessen

Ruth Dreessen has been appointed senior vice president, chief financial officer and a member of the advisory board of Westlake Group. She will assume overall responsibility for the finance, treasury, credit, insurance accounting and strategic planning activities of the company. Ms. Dreessen is a financial executive with experience in investment banking, corporate finance and mergers and acquisitions for a variety of industries.

Brent Fenton

Brent Fenton has been named vice president of North American oilseed processing at Archer Daniels Midland Company (ADM). He will be responsible for cottonseed crushing, canola seed crushing and Southern Cellulose Pro-ducts Inc., a subsidiary of ADM. Mr. Fenton joined the company in 1992.

Ginger L. Graham

Ginger L. Graham has been named president and CEO of Amylin Pharma-ceuticals Inc. effective September 1. Recently, Ms. Graham worked with Guidant Corp., where she was group chairman, office of the president. Dur-ing her seven-year tenure on Amylin's board of directors, Ms. Graham has chaired the audit committee and recently led a board-level strategic review of commercial plans for Symlin.

Steven P. James

Steven P. James has been appointed senior vice president of commercial operations at Exelixis Inc. He will be responsible for managing and expanding the company's business development and corporate development activities, and developing a strategy for precommercial and commercial operations. Mr. James has more than 20 years of biotechnology and pharmaceutical experience. He joins Exelixis from Sunesis Pharmaceuticals, where he served as chief business officer.

Juan Tobias Leon

Juan Tobias Leon has been appointed group leader for industrial products at Dexter Chemical LLC. He will lead the development of new formulations for its phosphate ester surfactants in architectural paint and industrial coatings formulations. Prior to joining the company, Mr. Leon was a senior chemist for Behr Process Corp.

Mike Livergood

Mike Livergood has been named vice president of North American oilseed processing at Archer Daniels Midland Company. He will be re-sponsible for sunflower seed and flaxseed crushing. Mr. Livergood will continue to be responsible for the specialty oils division. He joined the company in 1975.

Frank Luppino

Frank Luppino has been promoted to vice president of operations at Anika Therapeutics Inc. Prior to joining the company, Mr. Luppino was regional manager for ACC Consulting Group.

Wayne A. Marasco

Wayne A. Marasco has been elected to the board of directors of Corniche Group Inc. Dr. Marasco has more than 20 years of experience in academic and immunological research. He is a board certified physician specializing in the treatment of immunocompromised and HIV-1 infected patients.

Lawrence Mitchell

Lawrence Mitchell has been promoted to president of NineSigma Inc. Mr. Mitch-ell has more than 35 years of technical and general management experience. He will focus on accelerating the company's sales growth by creating strategic alli-ances with key customers. Prior to joining NineSigma, Mr. Mitchell was vice president and general manager of the engineered coatings division of Avery Dennsion's Concord, Ohio, operations.

Robert Monaghan

Robert Monaghan has joined the board of directors and been appointed CEO of Zyomyx Inc. He will be responsible for overseeing the ongoing development and commercialization of the company's protein profiling biochip system and protein biochips for pharmaceutical, biotechnology and academic customers. Mr. Monaghan has 25 years of product commercialization ex-perience and industry leadership. Most recently, he served as president of Sigma Diagnostics and its subsidiaries.

Charles Sweeney

Charles Sweeney has been appointed senior vice president, commercial operations for Southwest operations in Houston at Foster Wheeler USA Corp., a subsidiary of Foster Wheeler Ltd. Mr. Sweeney has 23 years of experience in the industry, 13 of which have been with Foster Wheeler.

Antonius J. Theunissen

Antonius J. Theunissen has been appointed president of Dyneon LLC, a wholly owned subsidiary of 3M. Mr. Theunissen comes to Dyneon from his most recent assignment as managing director of 3M Brazil. He has nearly 30 years of experience at 3M, including assignments in technology development, manufacturing and international business management.

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly